The Ultrastructure of Skeletal Muscle Capillaries of Streptozotocin Diabetic Rats and the Therapeutic Effect of Benfluorex
Source abstract
Abstract
Abstract Diabetes mellitus is a serious disease worldwide and causes other associated diseases. In this study, we observed the effect of streptozotocin (STZ)-induced diabetes and benfluorex treatment on muscular capillary ultrastructure. Adult male rats were used as the test subjects and each individual was intraperitoneally injected with one dose of STZ (45 mg/kg) to induce diabetes. Doses (50 mg/kg) of benfluorex were given to the subjects with tap water by intragastric gavage application once daily for 21 days. At the end of day 21, muscle tissues were obtained from animals and examined under transmission electron microscopy. From the data obtained with the electron microscope, it was observed that the control group had typical continuous capillary vascular structures in their muscles, while STZ caused disruptive disorder of the muscle cells in the capillary wall of the STZ-diabetic group. Additionally, the thickening of the basement membrane around endothelial cells, loss of mitochondrial crista in the muscle cells, enlarged endothelial cells, and narrowed vessel lumen were observed in the muscle tissue. The findings of our study revealed that STZ-induced diabetes disrupted the vascular structure, while benfluorex partially improved it.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Pharmacology and Obesity Treatment · Adipose Tissue and Metabolism · Pain Mechanisms and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Ankara University Faculty of Sciences, Biology Department, , Tandogan, Ankara 06100, Turkey
Gazi University School of Medicine, Physiology Department, , Besevler, Ankara 06500, Turkey
References (41)
Show source-provided references
1. Chronic administration of genistein improves aortic reactivity of streptozotocin-diabetic rats: Mode of action10.1016/j.vph.2008.03.002 ↗
2. Pericyte loss in diabetic retinopathy: Mechanisms and consequences10.2174/09298673113209990022 ↗
3. Ultrastructural aspects of human and canine diabetic retinopathy
4. Endothelial dysfunction coincides with an enhanced nitric oxide synthase expression and superoxide anion production10.1161/01.HYP.30.4.934 ↗
5. Mechanisms for the effects of benfluorex on the obese-diabetic-dyslipidemic syndrome10.1002/dmr.5610090509 ↗
6. Ultrastructural morphometry of capillary basement membrane thickness in normal and transgenic diabetic mice10.1002/ar.a.10038 ↗
7. Measurements of gluconeogenesis and glycogenolysis: A methodological review10.2337/db15-0640 ↗
8. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells10.1161/01.CIR.96.1.25 ↗
9. Cross · 1993
10. Streptozotocin-induced diabetes models: Pathophysiological mechanisms and fetal outcomes10.1155/2014/819065 ↗
11. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease10.2337/diacare.14.3.173 ↗
12. Benfluorex (mediator): Non-insulin-dependent diabetes and hypertriglyceridemia
13. Microvascular remodeling and wound healing: A role for pericytes10.1016/j.biocel.2012.06.031 ↗
14. Importance of pericytes and mechanisms of pericyte loss during diabetic retinopathy10.1111/j.1463-1326.2007.00795.x ↗
15. Fiallo-Scharer · 2004 · 411
16. Morphometric analysis of basal laminae in rats with long-term streptozotocin diabetes L. II. Retinal capillaries10.1016/0014-4835(83)90149-5 ↗
17. The ultrastructure of capillary basement membranes in the attached gingiva of diabetic and non-diabetic patients with periodontal disease10.1902/jop.1971.42.7.406 ↗
18. Streptozotocin-induced experimental diabetes in male wistar rats
19. Mechanisms by which diabetes increases cardiovascular disease10.1016/j.ddmec.2007.12.005 ↗
20. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus: Evidence for multiple sites of insulin resistance10.1172/JCI114142 ↗
21. Hadler · 1992
22. Hayat · 1981
23. Junqueira · 1998
24. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus10.5551/jat.RV17014 ↗
25. Streptozotocin-induced diabetes alters the serum lipid profiles of adult wistar rats
26. Added benfluorex in obese insulin-requiring type 2 diabetes
27. Vascular basement lamina thickness in the normal and inflamed gingiva of diabetics and non-diabetics10.1902/jop.1974.45.9.676 ↗
28. Endothelial function in hypertension10.1161/01.HYP.34.4.539 ↗
29. The effect of two exercise modalities on skeletal muscle capillary ultrastructure in individuals with type 2 diabetes10.1111/sms.13348 ↗
30. Cellular dysfunction in diabetes as maladaptive response to mitochondrial oxidative stress10.1155/2012/696215 ↗
31. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage10.1038/35008121 ↗
32. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I10.1093/eurheartj/eht149 ↗
33. Repair of alkali-labile sites within the mitochondrial DNA of RINr 38 cells after exposure to the nitrosourea streptozotocin10.1016/S0021-9258(18)49961-9 ↗
34. Valvular heart disease associated with benfluorex
35. Randall · 2000
36. Sekikawa · 1997 · 89
37. Degenerative vascular changes observed in selected gingival specimens10.1016/0030-4220(62)90415-2 ↗
38. Standards of medical care in diabetes10.2337/dc14-S014 ↗
39. Benfluorex and valvular heart disease: A cohort study of a million people with diabetes mellitus10.1002/pds.2044 ↗
40. Global prevalence of diabetes: Estimates for the year 2000 and projections for 203010.2337/diacare.27.10.2569-a ↗
41. Yönem · 2011 · 543